Infusion & Drug Delivery Devices
The U.S. infusion and drug delivery device market is growing with rising chronic disease prevalence, expanding home-based care, and increasing adoption of precise and connected medication delivery technologies. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across infusion pumps, wearable injectors, syringe pumps, implantable systems, and related accessories.
The U.S. Enteral Feeding Pumps Market is projected to grow from USD 0.75 billion in 2025 to USD 1.53 billion by 2035 at a 7.40% CAGR, driven by home enteral nutrition, aging demographics, neurological disorders, oncology nutrition, pediatric feeding needs, and adoption of portable feeding technologies.
Read Report Details
The U.S. Patient-Controlled Analgesia Pumps Market is projected to grow from USD 0.19 billion in 2025 to USD 0.38 billion by 2035 at a 7.20% CAGR, supported by smart PCA pump replacement, postoperative pain management, connected infusion systems, hospital safety initiatives, and expanding ambulatory pain-delivery workflows.
Read Report Details
The U.S. implantable infusion pumps market is projected to rise from $0.42 billion in 2025 to $0.81 billion by 2035, supported by targeted pain, spasticity, and oncology drug delivery.
Read Report Details
The U.S. Elastomeric Infusion Pumps Market is projected to grow from USD 0.23 billion in 2025 to approximately USD 0.50 billion by 2035 at an 8.10% CAGR, driven by home infusion, OPAT, ambulatory chemotherapy, and postoperative pain management.
Read Report Details
The U.S. Wearable Infusion Pumps Market is projected to grow from USD 3.88 billion in 2025 to USD 13.64 billion by 2035 at a 13.40% CAGR, driven by automated insulin delivery, home infusion, and wearable biologic drug delivery.
Read Report Details
The U.S. Ambulatory Infusion Pumps Market is projected to grow from USD 0.44 billion in 2025 to USD 1.42 billion by 2035 at a 12.4% CAGR, driven by home infusion, oncology, specialty biologics, pain management, and outpatient care expansion.
Read Report Details
The U.S. Syringe Infusion Pumps Market is projected to rise from USD 0.57 billion in 2025 to USD 1.37 billion by 2035 at a 9.17% CAGR, driven by smart pump adoption, EMR interoperability, critical-care demand, and hospital infusion-fleet modernization.
Read Report Details
The U.S. volumetric infusion pumps market is projected to rise from USD 0.55 billion in 2025 to USD 1.33 billion by 2035 at a 9.20% CAGR, supported by smart-pump replacement, interoperability, medication-safety requirements, and hospital infusion infrastructure modernization.
Read Report Details
The U.S. Large Volume Infusion Pumps Market is projected to grow from USD 1.18 billion in 2025 to USD 2.74 billion by 2035 at an 8.8% CAGR, driven by smart pump replacement, EHR interoperability, medication-safety modernization, and hospital fleet upgrades.
Read Report Details
The U.S. Smart Infusion Pumps Market is set to grow from USD 2.50B in 2025 to USD 5.89B by 2035 at an 8.95% CAGR.
Read Report Details